top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
IM Cannabis Corp. has regained compliance with Nasdaq Listing Rule 5550(b)(1) as of September 4, allowing its common stock to continue trading on the Nasdaq Capital Market. IM Cannabis Corp. (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, operating retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel, and distributing cannabis to pharmacies through Adjupharm GmbH in Germany.

IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement

Sep 10, 2025

Mg Magazine Newswire

MG Magazine



*TORONTO and GLIL YAM, Israel —* On September 4, Nasdaq notified IM
Cannabis Corp. that the company has regained compliance with Nasdaq Listing
Rule 5550(b)(1), which requires listed companies to maintain stockholders’
equity of at least $2,500,000. The Company’s common stock will continue to
be listed and traded on the Nasdaq Capital Market.
About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides
premium cannabis products to medical patients in Israel and Germany. The
Company operates medical cannabis retail pharmacies, online platforms,
distribution centers, and logistical hubs in Israel. In Germany, the IMC
ecosystem operates through Adjupharm GmbH, where it distributes cannabis to
pharmacies for medical cannabis patients.

Recent Reviews

bottom of page